Panacea Biotec Ltd PANACEABIO-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:28 PM IST
138.80quote price arrow up+0.75 (+0.54%)
Volume
42,256
52 week range
125.00 - 349.40
Loading...
  • Open140.95
  • Day High140.95
  • Day Low137.90
  • Prev Close138.05
  • 52 Week High349.40
  • 52 Week High Date08/09/21
  • 52 Week Low125.00
  • 52 Week Low Date07/28/22

Key Stats

  • Market Cap106.54M
  • Shares Out61.3M
  • 10 Day Average Volume98,542.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.43

KEY STATS

  • Open140.95
  • Day High140.95
  • Day Low137.90
  • Prev Close138.05
  • 52 Week High349.40
  • 52 Week High Date08/09/21
  • 52 Week Low125.00
  • 52 Week Low Date07/28/22
  • Market Cap106.54M
  • Shares Out61.3M
  • 10 Day Average Volume98,542.18
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.43

RATIOS/PROFITABILITY

  • EPS (TTM)175.99
  • P/E (TTM)0.79
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2006
  • Div Amount1.00
  • Split Date-
  • Split Factor-

Latest On Panacea Biotec Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Panacea Biotec Limited is an India-based biotechnology company, which is engaged in research and development, manufacturing, sales, distribution and marketing of pharmaceuticals, vaccines and biosimilars business. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product...
Soshil Jain
Whole-Time Chairman of the Board
Devender Gupta
Chief Financial Officer
Address
B-1 Extn / G-3
Mathura Road, Mohan Co-opIndlEstate
New Delhi
110044
India